News
Replimune Group, Inc. (NASDAQ: REPL), a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today announced that the U.S. Food and Drug Administration ...
Aquestive Therapeutics, Inc. (NASDAQ: AQST) ('Aquestive” or the 'Company”), a pharmaceutical company advancing medicines to bring meaningful improvement to patients' lives through innovative science ...
Medical professionals Timothy Holtz and Teri Mills worked with AIDS patients in the 1990s, when treatments were few. With ...
40m
The Brighterside of News on MSNTwo FDA-approved cancer drugs significantly reverse Alzheimer's disease
Alzheimer’s disease remains one of medicine’s toughest challenges, affecting millions and costing trillions of dollars ...
A Food and Drug Administration expert panel has reignited a debate over whether hormone therapy should be used to treat ...
The company agreed to voluntarily halt shipments of its experimental medicine Elevidys for Duchenne muscular dystrophy.
Explore more
Sarepta will halt all shipments of Elevidys, its drug for Duchenne muscular dystrophy patients, by Tuesday evening.
Long Island family alleges MRI technician invited Keith McAllister into room without metal warnings, leading to fatal ...
More than 67,200 Power Stick deodorants have been recalled due to manufacturing violations, according to the U.S. Food and ...
Companies are selling personalized compounded drugs that combine weight loss and erectile dysfunction treatments, but is this safe? No one can say because it’s all “personalized” compounded drugs ...
Wisconsinites for Alternatives to Smoking and Tobacco, Inc. (WiscoFAST) filed a lawsuit on June 30 to block the statewide ban ...
George Tidmarsh, a Stanford University physician who founded Horizon Pharma and later ran La Jolla Pharma, was named head of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results